Richard Peters

Biography

Richard Peters, M.D., Ph.D. has served as a member of our board of directors and our President and Chief Executive Officer since February 2017. Dr. Peters previously served as Senior Vice President and Head of Global Rare Diseases at Sanofi Genzyme, where he was responsible for a global, $3 billion per year business with 10 commercialized products and a multi-product development pipeline focused on several therapeutic areas. He also served as Head of Japan and Asia Pacific for Specialty Care (Oncology, Rare Diseases, Immunology, and Multiple Sclerosis) at Sanofi Genzyme. He is an expert in the field of Oncology, having previously served as Division Medical Officer at Sanofi Oncology, and is the former Head of Global and US Medical Affairs at Genzyme Transplant/Oncology. He has also served as a Senior Director at Onyx Pharmaceuticals, as a Director at Amgen, and as Chief Executive Officer of Mednav, a venture capital-backed healthcare information technology start-up. Dr. Peters is a Harvard-trained physician-scientist, and has served on the faculty at the Massachusetts General Hospital and completed a Howard Hughes Medical Institute Fellowship in biophysics at Harvard Medical School. He is also an active founder and angel biotech investor in start-up biopharmaceutical companies 

Research Interest

Merrimack helped develop the first high-density protein arrays, a groundbreaking technology at the time, that made the measurement of system dynamics possible. As a result, we were able to build computational models that could predict system behavior, and gain valuable insight into tumor anatomy, addiction, and adaptation.